Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypoxia-inducible factors and innate immunity in liver cancer
Vincent Wai‐Hin Yuen, Carmen Chak‐Lui Wong
Journal of Clinical Investigation (2020) Vol. 130, Iss. 10, pp. 5052-5062
Open Access | Times Cited: 137

Showing 1-25 of 137 citing articles:

Hypoxia-inducible factors: cancer progression and clinical translation
Elizabeth E. Wicks, Gregg L. Semenza
Journal of Clinical Investigation (2022) Vol. 132, Iss. 11
Open Access | Times Cited: 337
Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape
Qinghua Wu, You Li, Eugenie Nepovimová, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 255
The role of lipid metabolic reprogramming in tumor microenvironment
Kai Yang, Xiaokun Wang, Chenghu Song, et al.
Theranostics (2023) Vol. 13, Iss. 6, pp. 1774-1808
Open Access | Times Cited: 63
MicroRNA-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression
Yaojie Fu, Bryan Mackowiak, Dechun Feng, et al.
Gut (2023) Vol. 72, Iss. 10, pp. 1942-1958
Open Access | Times Cited: 44
Nanotechnology Reprogramming Metabolism for Enhanced Tumor Immunotherapy
Yangkai Zhou, Jing Yuan, Ke Xu, et al.
ACS Nano (2024) Vol. 18, Iss. 3, pp. 1846-1864
Closed Access | Times Cited: 20
Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression
Liang Wang, Liankang Sun, Runkun Liu, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 68
HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy
Shaima Salman, David J. Meyers, Elizabeth E. Wicks, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 9
Open Access | Times Cited: 67
Hypoxia-inducible factor-dependent ADAM12 expression mediates breast cancer invasion and metastasis
Ru Wang, Inês Godet, Yongkang Yang, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 19
Open Access | Times Cited: 65
Exosomal lncRNA HMMR‐AS1 mediates macrophage polarization through miR‐147a/ARID3A axis under hypoxia and affects the progression of hepatocellular carcinoma
Xu Wang, Yao Zhou, Ke Dong, et al.
Environmental Toxicology (2022) Vol. 37, Iss. 6, pp. 1357-1372
Closed Access | Times Cited: 50
Regulation and targeting of SREBP-1 in hepatocellular carcinoma
Fengting Su, Andreas Koeberle
Cancer and Metastasis Reviews (2023) Vol. 43, Iss. 2, pp. 673-708
Open Access | Times Cited: 33
Potential Pathophysiological Pathways in the Complex Relationships between OSA and Cancer
Manuel Sánchez‐de‐la‐Torre, Carolina Cubillos‐Zapata, Olivia J. Veatch, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1061-1061
Open Access | Times Cited: 26
Hypoxia-induced ZEB1 promotes cervical cancer immune evasion by strengthening the CD47-SIRPα axis
Xiaojing Chen, Chu-Hong Guo, Zi‐Ci Wang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Hypoxia-associated autophagy flux dysregulation in human cancers
Jiding Fu, Jie Lin, Zili Dai, et al.
Cancer Letters (2024) Vol. 590, pp. 216823-216823
Closed Access | Times Cited: 8
NK Cell Exosomes Alleviate PD-L1 Expression and Facilitate Tumor Immunity by Repressing PI3K-AKT-mTOR Signaling
Hang Xie, Yujie Wu, Jingyao Huang, et al.
Immunological Investigations (2025), pp. 1-14
Closed Access | Times Cited: 1
Histone citrullination by PADI4 is required for HIF-dependent transcriptional responses to hypoxia and tumor vascularization
Yufeng Wang, Yajing Lyu, Kangsheng Tu, et al.
Science Advances (2021) Vol. 7, Iss. 35
Open Access | Times Cited: 55
Severe hypoxia is a typical characteristic of human hepatocellular carcinoma: Scientific fact or fallacy?
Thorsten Cramer, Peter Vaupel
Journal of Hepatology (2022) Vol. 76, Iss. 4, pp. 975-980
Open Access | Times Cited: 32
Hypoxia signaling in hepatocellular carcinoma: Challenges and therapeutic opportunities
Shant Qinxiang Sin, Chakrabhavi Dhananjaya Mohan, Robby Miguel Goh, et al.
Cancer and Metastasis Reviews (2022) Vol. 42, Iss. 3, pp. 741-764
Closed Access | Times Cited: 29
Inflammatory processes involved in NASH-related hepatocellular carcinoma
Stefania Cannito, Umberto Dianzani, Maurizio Parola, et al.
Bioscience Reports (2023) Vol. 43, Iss. 1
Open Access | Times Cited: 18
Remodeling the hepatic fibrotic microenvironment with emerging nanotherapeutics: a comprehensive review
Xingtao Zhao, Felix Kwame Amevor, Xinyan Xue, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Hypoxia-driven tumor stromal remodeling and immunosuppressive microenvironment in scirrhous HCC
Shuling Chen, Changyi Liao, Huanjing Hu, et al.
Hepatology (2023) Vol. 79, Iss. 4, pp. 780-797
Closed Access | Times Cited: 17
Harnessing CD8+ T cell dynamics in hepatitis B virus‐associated liver diseases: Insights, therapies and future directions
Bing Yue, Yuxia Gao, Yi Hu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 7
Open Access | Times Cited: 7
MTHFD2-mediated redox homeostasis promotes gastric cancer progression under hypoxic conditions
Hai‐Yu Mo, Ruo-Bing Wang, Mengyao Ma, et al.
Redox Report (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 6
Beyond Cancer Cells: How the Tumor Microenvironment Drives Cancer Progression
Hussein Sabit, Borros Arneth, Shaimaa Abdel-Ghany, et al.
Cells (2024) Vol. 13, Iss. 19, pp. 1666-1666
Open Access | Times Cited: 6
A new acidic microenvironment related lncRNA signature predicts the prognosis of liver cancer patients
Peng Jiang, Wenbo Xue, Xi Cheng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 22
Advancements in understanding mechanisms of hepatocellular carcinoma radiosensitivity: A comprehensive review.
Gaoyuan Yang, Huamei Yan, Yongchang Tang, et al.
PubMed (2023) Vol. 35, Iss. 3, pp. 266-282
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top